Shuttle Pharmaceuticals Holdings (SHPH) Short term Debt (2025 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Short term Debt of $4.4 million for Q1 2026, little changed quarter-over-quarter from $4.4 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Short term Debt (2025 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Short term Debt history runs 2 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- In Q1 2026, Short term Debt changed N/A year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (changed N/A YoY), while the FY2025 annual figure was $4.4 million, changed N/A from the prior year.
- Short term Debt for Q1 2026 stood at $4.4 million, roughly flat from $4.4 million in the prior quarter.
- The five-year high for Short term Debt was $4.4 million in Q4 2025, with the low at $4.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.44 Mn |
| Dec 31, 2025 | 4.44 Mn |